Arcadia Biosciences, Inc. (RKDA) Total liabilities 2017–2025
Arcadia Biosciences, Inc. (RKDA) total liabilities at each fiscal year-end, per SEC filings.
$2.4MFY2025 · since FY2017: $8.6M → $2.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.4M | -67.0% |
| FY2024 | $7.3M | +4.2% |
| FY2023 | $7.0M | -12.7% |
| FY2022 | $8.0M | -36.9% |
| FY2021 | $12.7M | -32.3% |
| FY2020 | $18.8M | -22.5% |
| FY2019 | $24.2M | +116.3% |
| FY2018 | $11.2M | +30.9% |
| FY2017 | $8.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice